Vulvar Disease in Nigeria Observational Study

Condition(s) studied

Investigational drug(s) / intervention(s)

Observation: Observing for disease prevalence - actual and self-reported

Study summary

Vulvar disease in Nigeria A look at awareness within patients and health practitioners, self-reported and actual prevalence within communities in Nigeria

Eligibility

Primary outcome measure(s)

• Prevalence of Vulvar disease — 1-12 months
  Awareness of Vulvar disease (descriptor)

Trial sites (1)